Home » sepsis

sepsis

Dec 27, 2018

BioFire Bloodstream Infection Test Has Little Effect on Clinician Prescribing Behavior, Mayo Study Finds

Premium

The research highlighted particular challenges for gram-negative organisms among a population of higher-risk patients.

Dec 26, 2018

GenMark Fungal Blood Culture Test Clears FDA

The test is the second of three panels intended to detect pathogens that cause the bloodstream infections that can lead to sepsis.

Dec 20, 2018

GenMark Diagnostics Receives FDA Clearance for ePlex BCID Gram-Positive Panel

The firm had also applied for marketing clearance for its gram negative and fungal pathogen panels in October.

Nov 29, 2018

Methylation Atlas Aims to Link Cell-Free DNA to Tissue, Cell Types of Origin

With a DNA methylation atlas and deconvolution algorithm, researchers are attempting to trace cfDNA back to tissue sources in healthy or ill individuals.

Nov 29, 2018

Nanopore Platform Developers Aim to Bring Multiplex MDx Testing to Point of Care

Premium

The UK developers believe that their device has the potential for multiplex testing at the point of care using solid-state nanopore sensing with DNA probes.

Nov 02, 2018

DNAe Receives $10.9M From BARDA for Near-Patient NGS Prototype

The award comes after DNAe completed the first phase of a contract valued at up to $51.9 million, which BARDA initiated in September 2016.

Oct 24, 2018

Sequencing Method Screens for All Known Bacterial Pathogens, Resistance Markers

Premium

Columbia University researchers have adapted a capture-based targeted sequencing method for viral genomes to detect bacteria in clinical samples. 

Oct 08, 2018

Karius Collaborators Report Interim Study Results at IDWeek

Premium

The Stanford spinout has launched an infectious disease test that sequences cell-free pathogen DNA to diagnose sepsis in immunocompromised patients.

Oct 02, 2018

GenMark Submits ePlex BCID Gram-Negative, Fungal Pathogen Panels for FDA Clearance

The firm has completed submissions for all three of its ePlex panels for diagnosis and management of bloodstream infections that can lead to sepsis.

Aug 23, 2018

Luminex Verigene MDx Panel Speeds Up AST, Reduces Cost, Study Finds

Premium

Clinicians identifying and treating S. aureus bloodstream infections reduced the median length of stay by 5.6 days and hospital cost by $13,341 per patient after using Luminex's assay.

Pages

The Scan

And Deal

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Positive Review

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

For Long Life

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

This Week in Nucleic Acids Research

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.